David Cole to Vaccines, Synthetic
This is a "connection" page, showing publications David Cole has written about Vaccines, Synthetic.
Connection Strength
0.196
-
Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge. Hum Gene Ther. 1996 Jul 10; 7(11):1381-94.
Score: 0.132
-
A phase II study of active immunotherapy with PANVAC or autologous, cultured dendritic cells infected with PANVAC after complete resection of hepatic metastases of colorectal carcinoma. Clin Colorectal Cancer. 2006 Jan; 5(5):368-71.
Score: 0.064